PASG logo

PASG Passage Bio Inc

$4.80
$0.00
(0.00%)
Today
Closed $4.80
$0.00
(0.00%)
After Hours
34

Bearish Sentiment

How do you feel about PASG?

Loading...
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG PR Newswire NEW YORK, July 23, 2026 NEW YORK, July 23, 2026 /PRNewswire...
PR Newswire
SPRY, PASG, BOXL: Why These Stocks Plunged Double Digits In After-Hours Trading Today
The after-hours decline was driven by concerns over trading activity, business performance and company restructuring plans.
Stocktwits
PASG Stock Slumps 16% After-Hours — What’s Driving The Selloff?
Passage Bio said on Wednesday that it will merge with privately held Remix Therapeutics.
Stocktwits
Passage Bio Inc (PASG) Stock: Should You Buy the Dip For 125% Upside?
Passage Bio Inc (PASG) Stock: Should You Buy the Dip For 125% Upside...
Yahoo! Finance: News
This Mohawk Industries Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Tuesday
Wall Street analysts changed outlook for top names, including downgrading Mohawk Industries and Passage Bio. See analyst ratings for these stocks.read more...
Benzinga
Passage Bio (NASDAQ:PASG) CEO Sells $75,161.44 in Stock
Passage Bio, Inc. (NASDAQ:PASG - Get Free Report) CEO William Chou sold 4,076 shares of the business's stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of...
MarketBeat
Insider Selling: Passage Bio (NASDAQ:PASG) CEO Sells $75,161.44 in Stock
Passage Bio, Inc. (NASDAQ:PASG - Get Free Report) CEO William Chou sold 4,076 shares of the firm's stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of...
MarketBeat
PASSAGE BIO, INC. Q3 Loss Decreases, Beats Estimates
(RTTNews) - PASSAGE BIO, INC. (PASG) announced Loss for third quarter that decreased from the same period last year and beat the Street estimates...
Nasdaq News: Markets
Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet
The mean of analysts' price targets for Passage Bio (PASG) points to a 731% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks